China's Best One-Stop Medical Equipment Provider
About

Carthera is a clinical-stage medtech company based in France, founded in 2010 by Professor Alexandre Carpentier. The company focuses on developing innovative ultrasound-based medical devices to treat severe brain disorders, including glioblastoma and other central nervous system diseases. Carthera's flagship product is the SonoCloud, an intracranial implant that uses low intensity pulsed ultrasound to temporarily open the blood-brain barrier. This technology enhances the delivery of chemotherapy drugs directly to brain tumors, improving treatment efficacy. The company is actively involved in clinical trials and research collaborations to validate and expand the applications of its ultrasound technologies. Carthera serves patients with severe brain diseases, medical institutions, and healthcare providers seeking non-invasive treatment options. The company is committed to advancing its innovative solutions and regularly participates in scientific research and medical conferences.

Technologies
MailJetreCAPTCHAGoogle Tag ManagerWordPress.orgYouTubeMobile FriendlyMicro
Keywords
medical devicesneurosurgerytherapeutic ultrasoundneurooncologymedical equipment manufacturingbiotechnologyultrasound resonatorultrasound in neuro-oncologyregenerative medicinemicrobubbles infusionreversible blood-brain barrier openingmedical equipment and supplies manufacturingultrasound therapybrain tumor treatmentultrasound-mediated drug deliveryglioblastoma therapyblood-brain barrier openingtargeted brain therapyneurotechnologyhealthcareblood-brain barrier disruptionservicesimmunotherapy deliverybrain metastases treatmentsonocloud implantable devicepharmaceuticalsultrasound for cns diseasesmedical deviceultrasound for neurodegenerative diseasesimplantable ultrasound device
Company Information
  • Employees29
  • Founded2010
  • Annual Revenue$5200000
  • Total Funding$81107541
Location

Lyon, Rhone-Alpes, France

Related Companies
Companies in the same industry